// App-Quantinova.ai

14782 : Impact of Black Race on Progression to End-Stage Renal Disease Despite Similar Outcomes for Cardiovascular Morbidity and Mortality: The TREAT Study

Researchers

Presenter

  • John McMurray

Principal Investigators

  • Robert Toto

  • Scott Solomon

  • Patrick Parfrey

  • Kai-Uwe Eckardt

  • Peter Ivanovich

  • Emmanuel Burdmann

  • Andrew Levey

  • Marc Pfeffer

Medical Centers

  • Northwestern University, Chicago, IL

  • Univsklinikum Erlangen-Nureemberg, Erlangen, Germany

  • Faculdade de Medicina de Sao Jose do Rio Preto, Sao Jose do Rio Preto, Brazil

  • Tufts New England Medical Center, Boston, MA

  • Univ Texas Southwest Med Ctr, Dallas, TX

  • Brigham & Women's Hospital, Boston, MA

  • University of Glasgow, Glasgow, United Kingdom

  • Health Sciences Centre, St. Johns, NF, Canada

Locations

  • Brazil

  • Canada

  • Germany

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

Disease

  • Microvascular complications of diabetes 1

  • Chronic kidney disease

  • Type 2 diabetes mellitus

  • Renal disease

  • Diabetes

  • Anemia

  • Stroke

  • End stage renal disease

Biomarkers

  • N/A

Drug/Treatment

  • Aranesp

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved